Found 11 matching trials
Panitumumab and Irinotecan for Malignant Gliomas PHASE2 This is a phase II study of the combination of panitumumab with irinotecan ...
Show More Location
The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center
Learn More & Join Trial
Phase II Study of Irinotecan and Panitumumab PHASE2 This study proposes a single-arm, phase II study of irinotecan with panitum...
Show More Location
University of Pittsburgh Cancer Institute
Learn More & Join Trial
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer PHASE2 RATIONALE: Erlotinib hydrochloride may stop the growth of tumor cells by bl...
Show More Location
Cancer Care & Hematology Specialists of Chicagoland
Learn More & Join Trial
Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer PHASE2 RATIONALE: Monoclonal antibodies, such as panitumumab, can block tumor grow...
Show More Location
Centre Paul Papin
Learn More & Join Trial
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma PHASE2 This study is being done to answer the following question:
Is the combinat...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver PHASE2 The purpose of this study is to see if patients treated with both regional ...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer PHASE2 The purpose of this study is to see if Panitumumab plus the other treatment...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial
Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC PHASE2 The purpose of this study is to assess the objective response rate (ORR) wh...
Show More Location
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
Learn More & Join Trial
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma PHASE2 This study is being done to answer the following question:
Is the combinat...
Show More Location
Virginia mason medical Center
Learn More & Join Trial
FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer PHASE2 This phase II trial studies how well fluorouracil, leucovorin calcium, and ...
Show More Location
City of Hope Medical Center
Learn More & Join Trial